New Alzheimer’s drug rejected for widespread NHS use in England

Donanemab, a pioneering new drug that can treat Alzheimer's, has been rejected by the health spending watchdog.

Wednesday 23 October 2024 11:54, UK

The National Institute of Health and Care Excellence said that the new drug for treating the disease "does not currently demonstrate value for the NHS".
Why you can trust Paste BN

Watch Next